<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39390084</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2731-7013</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Dermatologie (Heidelberg, Germany)</Title><ISOAbbreviation>Dermatologie (Heidelb)</ISOAbbreviation></Journal><ArticleTitle>[Effects of the COVID-19 pandemic on inpatient dermatosurgery in Germany : Retrospective evaluation of the surgical cases from nine dermatology clinics].</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00105-024-05417-5</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Currently, only little data is available on the impact of the COVID-19 pandemic on inpatient dermatosurgical care in German dermatological clinics.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective analysis of all dermatosurgical cases that were treated in inpatient setting in nine German dermatological clinics in four federal states in 2019, 2020 and 2021 was performed. The diagnoses were recorded using the ICD-10 codes. In addition, demographic data such as age, gender and the length of inpatient stay were analysed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2019, 2020 and 2021, a total of 10,739, 9185 and 9828 dermatosurgical inpatients were treated respectively. Thus, the reduction of inpatient dermatosurgical cases was 14.5% in 2020 and 8.5% in 2021 compared to 2019. Inpatient surgical treatment of melanoma decreased by 10.1% of cases in 2020. This decrease was only 1.4% in 2021 compared to 2019. The number of inpatient surgeries performed for benign lesions such as melanocytic nevi or viral warts reduced sharply in both pandemic years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data show for the first time how inpatient care for the entire spectrum of dermatosurgical diseases developed during the COVID-19 pandemic in Germany. After the initial marked decline in inpatient dermatosurgical cases in 2020, there was less difference in 2021 compared to 2019. This trend can be interpreted as an indication that there is still a strong need for inpatient dermatosurgical care that cannot yet be met on an outpatient basis.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Balakirski</LastName><ForeName>Galina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Zentrum für Dermatologie, Allergologie und Dermatochirurgie, Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Deutschland. galina.balakirski@helios-gesundheit.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assaf</LastName><ForeName>Chalid</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Klinik für Dermatologie und Venerologie, Helios Klinikum Krefeld, Krefeld, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dippel</LastName><ForeName>Edgar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hautklinik, Klinikum Ludwigshafen am Rhein, Ludwigshafen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fröhlich</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Zentrum für Hauterkrankungen, Universitätsklinikum Bonn, Bonn, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kofler</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hautklinik, Universitätsklinikum Tübingen, Tübingen, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hautzentrum am Holzmarkt, Holzmarkt 6, 88400, Biberach, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreuter</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Klinik für Dermatologie, Venerologie und Allergologie, Helios St. Elisabeth Klinik Oberhausen, Oberhausen, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Klinik für Dermatologie, Venerologie und Allergologie, Helios St. Johannes Klinik Duisburg, Duisburg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunte</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Abteilung für Dermatochirurgie und Dermatologie, Artemed Fachklinik München, München, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Klinik und Poliklinik für Dermatologie und Allergologie, LMU München, München, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmann</LastName><ForeName>Silke C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Zentrum für Dermatologie, Allergologie und Dermatochirurgie, Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Klinik für Dermatologie und Venerologie, Helios Klinikum Krefeld, Krefeld, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neubert</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Zentrum für Dermatologie, Allergologie und Dermatochirurgie, Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pumnea</LastName><ForeName>Teodora</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Klinik und Poliklinik für Dermatologie und Allergologie, LMU München, München, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Laurenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Klinik für Dermatologie und Allergologie, Universitätsklinikum der RWTH Aachen, Aachen, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hautklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazdi</LastName><ForeName>Amir S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Klinik für Dermatologie und Allergologie, Universitätsklinikum der RWTH Aachen, Aachen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Löser</LastName><ForeName>Christoph R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Hautklinik, Klinikum Ludwigshafen am Rhein, Ludwigshafen, Deutschland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Auswirkungen der COVID-19-Pandemie auf die stationäre Dermatochirurgie in Deutschland : Retrospektive Auswertung der operativen Fälle aus neun Hautkliniken.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dermatologie (Heidelb)</MedlineTA><NlmUniqueID>9918384885206676</NlmUniqueID><ISSNLinking>2731-7005</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="ZUSAMMENFASSUNG" NlmCategory="UNASSIGNED">EINLEITUNG: Aktuell existieren nur wenige Daten über die Beeinträchtigung der stationären dermatochirurgischen Versorgung in deutschen Hautkliniken durch die COVID-19-Pandemie.</AbstractText><AbstractText Label="METHODEN" NlmCategory="METHODS">Es erfolgte eine retrospektive Auswertung aller dermatochirurgischen Fälle, die in den Jahren 2019, 2020 und 2021 in 9 deutschen Hautkliniken in 4 Bundesländern stationär behandelt wurden. Die Diagnosen wurden anhand der ICD-10-Codes erfasst. Zusätzlich wurden demografische Daten wie Alter und Geschlecht sowie die stationäre Verweildauer ausgewertet.</AbstractText><AbstractText Label="ERGEBNISSE" NlmCategory="UNASSIGNED">In den Jahren 2019, 2020 und 2021 wurden jeweils 10.739, 9185 und 9828 dermatochirurgische Patienten stationär behandelt. Somit betrug die Reduktion der stationären dermatochirurgischen Fälle im Jahr 2020 14,5 % und im Jahr 2021 8,5 % im Vergleich zum Jahr 2019. Die stationäre operative Versorgung der Melanome ging im Jahr 2020 um 10,1 % der Fälle zurück. Im Jahr 2021 betrug dieser Rückgang nur noch 1,4 % im Vergleich zum Jahr 2019. Die stationäre operative Versorgung benigner Veränderungen wie Melanozytennävi oder Viruswarzen zeigte in beiden Pandemiejahren eine starke Regression.</AbstractText><AbstractText Label="DISKUSSION" NlmCategory="CONCLUSIONS">Unsere Daten erfassen erstmalig und repräsentativ die Entwicklung der stationären Versorgung des gesamten dermatochirurgischen Erkrankungsspektrums im Rahmen der COVID-19-Pandemie in Deutschland. Nach dem initial starken Rückgang der stationären dermatochirurgischen Fälle im Jahr 2020 zeigte sich im Jahr 2021 eine geringere Differenz zu 2019. Diese Tendenz kann als Hinweis gedeutet werden, dass für eine stationäre dermatochirurgische Versorgung weiterhin ein starker Bedarf besteht, der bis dato ambulant nicht aufgefangen werden kann.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Care situation</Keyword><Keyword MajorTopicYN="N">Demographic analysis</Keyword><Keyword MajorTopicYN="N">Dermatosurgical spectrum of disease</Keyword><Keyword MajorTopicYN="N">Long-term effect</Keyword><Keyword MajorTopicYN="N">Malignant melanoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>0</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>0</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39390084</ArticleId><ArticleId IdType="doi">10.1007/s00105-024-05417-5</ArticleId><ArticleId IdType="pii">10.1007/s00105-024-05417-5</ArticleId></ArticleIdList><ReferenceList><Title>Literatur</Title><Reference><Citation>Webseite des Bundesgesundheitsministeriums https://www.bundesgesundheitsministerium.de/coronavirus/chronik-coronavirus . Zugegriffen: 14. Dez. 2023</Citation></Reference><Reference><Citation>Webseite der Bundesregierung https://www.bundesregierung.de/breg-de/themen/coronavirus/ende-corona-massnahmen-2068856 . Zugegriffen: 14. Dez. 2023</Citation></Reference><Reference><Citation>Hafner J, Löser CR, Roka F (2023) Dermatosurgery—from surgical option to integral part of dermatologic therapy. J Dtsch Dermatol Ges 21(4):355–358</Citation><ArticleIdList><ArticleId IdType="pubmed">37070496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel R, Pollard B, Council ML (2023) Impact of COVID-19 on dermatologic surgery: experience of a Midwestern academic practice. Arch Dermatol Res 315(1):85–87</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00403-021-02284-1</ArticleId><ArticleId IdType="pubmed">34628518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gironi LC, Boggio P, Giorgione R et al (2022) The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone. J Dermatolog Treat 33(2):897–903</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09546634.2020.1789044</ArticleId><ArticleId IdType="pubmed">32600085</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan GS, Dunne JA, Kiely AL et al (2020) The effect of the COVID-19 pandemic on skin cancer surgery in the United Kingdom: a national, multi-centre, prospective cohort study and survey of Plastic Surgeons. Br J Surg 107(12):e598–e600</Citation><ArticleIdList><ArticleId IdType="pubmed">32936450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lallas A, Kyrgidis A, Manoli SM et al (2021) Delayed skin cancer diagnosis in 2020 because of the COVID-19 related restrictions: Data from an institutional registry. J Am Acad Dermatol 85(3):721–723</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2021.05.021</ArticleId><ArticleId IdType="pubmed">34052332</ArticleId><ArticleId IdType="pmc">8156834</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon AB, Sharon CE, Straker RJ et al (2021) The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience. J Am Acad Dermatol 84(4):1096–1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.12.034</ArticleId><ArticleId IdType="pubmed">33352269</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinier R, Roger A, Genet B et al (2022) Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity. J Eur Acad Dermatol Venereol 36:e164–e166</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.17802</ArticleId><ArticleId IdType="pubmed">34753221</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf C, Brancaccio G, Di Stefani A et al (2022) The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe. J Am Acad Dermatol 87(3):648–649</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2022.05.018</ArticleId><ArticleId IdType="pubmed">35588928</ArticleId><ArticleId IdType="pmc">9110066</ArticleId></ArticleIdList></Reference><Reference><Citation>Marson JW, Maner BS, Harding TP et al (2021) The magnitude of COVID-19’s effect on the timely management of melanoma and nonmelanoma skin cancers. J Am Acad Dermatol 84:1100–1103</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.12.065</ArticleId><ArticleId IdType="pubmed">33482258</ArticleId><ArticleId IdType="pmc">7817517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejera-Vaquerizo A, Nagore E (2020) Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model. J Eur Acad Dermatol Venereol 34(8):e351–e353</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.16555</ArticleId><ArticleId IdType="pubmed">32362041</ArticleId><ArticleId IdType="pmc">7267312</ArticleId></ArticleIdList></Reference><Reference><Citation>Balakirski G, Hofmann SC, Isselmann N et al (2023) Effects of the COVID-19 pandemic on inpatient skin surgery in Germany: results of the DESSI-survey. J Dtsch Dermatol Ges 21(7):727–738</Citation><ArticleIdList><ArticleId IdType="pubmed">37427731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleemann J, Meissner M, Özistanbullu D et al (2022) Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany—a nationwide analysis. J Eur Acad Dermatol Venereol 36(10):1766–1773</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.18217</ArticleId><ArticleId IdType="pubmed">35570468</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigtländer S, Hakimhashemi A, Grundmann N (2023) Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J Cancer Res Clin Oncol 149(10):7493–7503</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-023-04707-0</ArticleId><ArticleId IdType="pubmed">36964405</ArticleId><ArticleId IdType="pmc">10038367</ArticleId></ArticleIdList></Reference><Reference><Citation>Balakirski G, Michalowitz AL, Kreuter A, Hofmann SC (2022) Long-term effects of the COVID-19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics. J Eur Acad Dermatol Venereol 36(10):e762–e764</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.18337</ArticleId><ArticleId IdType="pubmed">35723886</ArticleId></ArticleIdList></Reference><Reference><Citation>Balakirski G, Sabulyte S, Wesselmann U et al (2023) Long-term effects of the COVID-19 pandemic on cutaneous squamous cell carcinoma: Increase of thick tumors in two german dermatology clinics. J Dtsch Dermatol Ges 21(8):910–913</Citation><ArticleIdList><ArticleId IdType="pubmed">37574681</ArticleId></ArticleIdList></Reference><Reference><Citation>Thierse K (2020) MDK-Prüfungen: Kompetenz und geltendes Recht. Dtsch Ärztebl 117(8):A-398</Citation></Reference><Reference><Citation>Kuntz T, Siebdrath J, Hofmann SC et al (2022) Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers. J Dtsch Dermatol Ges 20(12):1581–1588</Citation><ArticleIdList><ArticleId IdType="pubmed">36508370</ArticleId></ArticleIdList></Reference><Reference><Citation>Saur A, Stenger F, Pfefferle V, Häfner HM, Kofler L (2022) Surgical therapy of congenital nevi using power-stretching technique on the forehead. J Dtsch Dermatol Ges 20(11):1527–1529</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ddg.14868</ArticleId><ArticleId IdType="pubmed">36259266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler K, Häfner HM, Forchhammer S, Kofler L (2023) Surgical treatment of nevi in children in a dermatological surgery center: Histopathology and complications. Dermatologie 74(7):520–526</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00105-023-05147-0</ArticleId><ArticleId IdType="pubmed">37119200</ArticleId></ArticleIdList></Reference><Reference><Citation>Matic KM (2021) SARS-CoV‑2 and Multisystem Inflammatory Syndrome In Children (MIS-C). Curr Probl Pediatr Adolesc Health Care 51(4):101000</Citation><ArticleIdList><ArticleId IdType="pubmed">34120861</ArticleId><ArticleId IdType="pmc">8114765</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuschenbach M, Mihm S, Wölle R et al (2020) Burden of HPV related anogenital diseases in young women in Germany—an analysis of German statutory health insurance claims data from 2012 to 2017. BMC Infect Dis 20(1):297</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05002-w</ArticleId><ArticleId IdType="pubmed">32321435</ArticleId><ArticleId IdType="pmc">7178589</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB (2021) Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 35(1):50–61</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.16677</ArticleId><ArticleId IdType="pubmed">32460374</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis EJ, Bettoli V, Jemec GBE et al (2021) Anti-COVID-19 measurements for hidradenitis suppurativa patients. Exp Dermatol 30 Suppl 1(1):18–22</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.14339</ArticleId><ArticleId IdType="pubmed">34085330</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiocco Z, Schlager JG, Kendziora B et al (2022) Impact of the COVID-19 pandemic on patients with hidradenitis suppurativa. Int Wound J 19(7):1686–1692</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iwj.13772</ArticleId><ArticleId IdType="pubmed">35128802</ArticleId><ArticleId IdType="pmc">9111782</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlager JG, Kendziora B, Patzak L et al (2021) Impact of COVID-19 on wound care in Germany. Int Wound J 18(4):536–542</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iwj.13553</ArticleId><ArticleId IdType="pubmed">33554436</ArticleId><ArticleId IdType="pmc">8014846</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest JF, Fuller GW (2023) Cohort study assessing the impact of COVID-19 on venous leg ulcer management and associated clinical outcomes in clinical practice in the UK. BMJ Open 13(2):e68845</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-068845</ArticleId><ArticleId IdType="pubmed">36806131</ArticleId><ArticleId IdType="pmc">9944296</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeer B, Helms G, Pasternak et al (2023) Back to the future: breast surgery with tumescent local anesthesia (TLA)? Arch Gynecol Obstet 308(3):935–940</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-023-06938-5</ArticleId><ArticleId IdType="pubmed">36872392</ArticleId><ArticleId IdType="pmc">10348980</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiter U, Keim U, Eigentler T et al (2017) Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany. J Invest Dermatol 137(9):1860–1867</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2017.04.020</ArticleId><ArticleId IdType="pubmed">28487088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>